tiprankstipranks
Trending News
More News >
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
Advertisement

Nautilus Biotechnolgy (NAUT) Earnings Dates, Call Summary & Reports

Compare
159 Followers

Earnings Data

Report Date
Feb 19, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.14
Last Year’s EPS
-0.14
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 28, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized significant scientific and operational progress, expansion of strategic partnerships, and positive market feedback, tempered by the acknowledgment of limited near-term revenue expectations.
Company Guidance
In the third quarter of 2025, Nautilus Biotechnology provided guidance on their operational and financial progress, focusing on their path towards commercialization. They reported total operating expenses of $15.5 million, reflecting a 19% year-over-year decrease due to improved operating efficiency and lower development costs. The company ended the quarter with $168.5 million in cash, cash equivalents, and investments, and a cash burn of $11.0 million, projecting a cash runway extending through 2027. Nautilus emphasized their strategic collaborations, including partnerships with the Buck Institute for Research on Aging and the Allen Institute for Brain Science, to explore proteoform-based biomarkers for neurodegenerative diseases. The company plans to launch their early access program for the Tau proteoform assay in the first half of 2026, with limited revenue expected initially, but significant potential for future commercial opportunities. Nautilus is also progressing towards the broadscale commercial launch of their platform in late 2026, following promising early results from their new assay configuration.
Scientific Platform Progress
Meaningful progress in scientific platform with the publication of a preprint showcasing the iterative mapping method and new collaborations with renowned institutes like the Neuro Stem Cell Institute, Mount Sinai Medical Center, and the Allen Institute for Brain Science.
Partnership with Buck Institute
Collaboration with the Buck Institute for Research on Aging to examine Tau proteoforms related to Alzheimer's disease, with results to be presented at the Human Proteome Organization's World HUPO Conference.
Expansion of Collaborator Pipeline
Significant expansion of potential collaborators, including academic centers, nonprofit institutes, and biopharma companies, interested in exploring proteoform-based precision biomarkers.
Market Research and Customer Insights
Completion of market study involving over 250 decision-makers, highlighting Nautilus platform's competitive differentiation and strong market fit with willingness to pay a premium for the solution.
Financial Discipline and Cash Runway
Reduction in operating expenses by 19% year-over-year, with a cash runway extending through 2027, reflecting strong financial discipline.

Nautilus Biotechnolgy (NAUT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NAUT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 19, 2026
2025 (Q4)
-0.14 / -
-0.14
Oct 28, 2025
2025 (Q3)
-0.15 / -0.11
-0.1315.38% (+0.02)
Jul 31, 2025
2025 (Q2)
-0.15 / -0.12
-0.1414.29% (+0.02)
Apr 29, 2025
2025 (Q1)
-0.15 / -0.13
-0.1513.33% (+0.02)
Feb 27, 2025
2024 (Q4)
-0.15 / -0.14
-0.140.00% (0.00)
Oct 29, 2024
2024 (Q3)
-0.17 / -0.13
-0.130.00% (0.00)
Jul 30, 2024
2024 (Q2)
-0.16 / -0.14
-0.13-7.69% (-0.01)
Apr 30, 2024
2024 (Q1)
-0.16 / -0.15
-0.12-25.00% (-0.03)
Feb 28, 2024
2023 (Q4)
-0.16 / -0.14
-0.11-27.27% (-0.03)
Oct 31, 2023
2023 (Q3)
-0.15 / -0.13
-0.11-18.18% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NAUT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 28, 2025
$1.35$1.43+5.93%
Jul 31, 2025
$0.76$0.760.00%
Apr 29, 2025
$0.68$0.73+7.35%
Feb 27, 2025
$1.43$1.17-18.18%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nautilus Biotechnolgy (NAUT) report earnings?
Nautilus Biotechnolgy (NAUT) is schdueled to report earning on Feb 19, 2026, Before Open (Confirmed).
    What is Nautilus Biotechnolgy (NAUT) earnings time?
    Nautilus Biotechnolgy (NAUT) earnings time is at Feb 19, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NAUT EPS forecast?
          NAUT EPS forecast for the fiscal quarter 2025 (Q4) is -0.14.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis